: The American Society of Anesthesiologists (ASA) reinforces the use of technique-based relief, such as fascial plane blocks, to reduce opioid needs after surgery [32].
: In January 2025, the FDA approved Journavx (Suzetrigine) , the first non-opioid analgesic for moderate to severe acute pain, signaling a major step toward these new standards [33, 34]. Chronic
On the health front, the FDA recently released a landmark draft guidance titled [1, 9]. This document aims to break the cycle of opioid reliance by accelerating the development of safer alternatives. : The American Society of Anesthesiologists (ASA) reinforces
: This follows a similar slide by 2025 prospect Will Johnson , who fell to the 47th pick over fears that chronic injuries would shorten his professional career [24]. This document aims to break the cycle of
: Use heat/cold therapy and pacing to manage daily activity [25, 36].
For the millions of Americans currently living with persistent symptoms, specialists at Sports Medicine of the Rockies and the Mayo Clinic suggest a multidisciplinary approach:
: Organizations like SIGN are also updating their recommendations to emphasize that opioids should not be routinely prescribed for chronic pain due to insufficient evidence of long-term benefit [27, 35]. Managing Life with Chronic Pain